Not yet recruiting
Conjunctivitis allergic+3
Not yet recruitingEfficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma
Registered drug
Efficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma
Registered drug
- Disease:Conjunctivitis allergicSeasonal allergy+2
- Substances:BilastineMometasone Furoate+7
Countries:
Poland
Poland- Participants:0–17 years · 18–64 years
- Substances:Bilastine
- Sponsor:Inmunotek S.L.
